Primary Erythermalgia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
To identify the mutation of SCN9A in a Chinese Han family with typical symptoms of PE and study the electrophysiological effect of the identified mutation.
|
28990532 |
2017 |
Primary Erythermalgia
|
0.800 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Small fibre neuropathy.
|
28665811 |
2017 |
Primary Erythermalgia
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Molecular diagnostic experience of whole-exome sequencing in adult patients.
|
26633545 |
2016 |
Primary Erythermalgia
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Inherited pain: sodium channel Nav1.7 A1632T mutation causes erythromelalgia due to a shift of fast inactivation.
|
24311784 |
2014 |
Primary Erythermalgia
|
0.800 |
Biomarker
|
disease |
BEFREE |
Autonomic dysfunction in SCN9A-associated primary erythromelalgia.
|
23152140 |
2013 |
Primary Erythermalgia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Mutations in human SCN9A gene, encoding the α-subunit of the voltage-gated sodium channel, Na(v)1.7, were found to be responsible for PE.
|
23383113 |
2013 |
Primary Erythermalgia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Severe case and literature review of primary erythromelalgia: novel SCN9A gene mutation.
|
22033523 |
2012 |
Primary Erythermalgia
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Treatment of Na(v)1.7-mediated pain in inherited erythromelalgia using a novel sodium channel blocker.
|
22035805 |
2012 |
Primary Erythermalgia
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Gain of function Naν1.7 mutations in idiopathic small fiber neuropathy.
|
21698661 |
2012 |
Primary Erythermalgia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Here we present a PEM case with R1150W polymorphism in SCN9A and a five-year remission was achieved by chemical lumbar sympathectomy (CLS).
|
20959280 |
2011 |
Primary Erythermalgia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Mutations in SCN9A cause three human pain disorders: bi-allelic loss of function mutations result in Channelopathy-associated Insensitivity to Pain (CIP), whereas activating mutations cause severe episodic pain in Paroxysmal Extreme Pain Disorder (PEPD) and Primary Erythermalgia (PE).
|
20635406 |
2010 |
Primary Erythermalgia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the voltage-gated Na(V)1.7 Na(+) channel alpha1 gene SCN9A have been linked to pain disorders, such as inherited primary erythromelalgia and paroxysmal extreme pain disorder.
|
20074229 |
2010 |
Primary Erythermalgia
|
0.800 |
Biomarker
|
disease |
CTD_human |
A novel Nav1.7 mutation producing carbamazepine-responsive erythromelalgia.
|
19557861 |
2009 |
Primary Erythermalgia
|
0.800 |
Biomarker
|
disease |
CTD_human |
Treatment with carbamazepine and gabapentin of a patient with primary erythermalgia (erythromelalgia) identified to have a mutation in the SCN9A gene, encoding a voltage-gated sodium channel.
|
19549232 |
2009 |
Primary Erythermalgia
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Early- and late-onset inherited erythromelalgia: genotype-phenotype correlation.
|
19369487 |
2009 |
Primary Erythermalgia
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
NaV1.7 gain-of-function mutations as a continuum: A1632E displays physiological changes associated with erythromelalgia and paroxysmal extreme pain disorder mutations and produces symptoms of both disorders.
|
18945915 |
2008 |
Primary Erythermalgia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
We detected a low SCN9A mutation rate in patients with primary erythermalgia, suggesting that pain syndromes in the skin may have a polygenic basis.
|
18347287 |
2008 |
Primary Erythermalgia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
We found a novel mutation of SCN9A, which is a responsible gene for primary erythermalgia in this case.
|
17985268 |
2007 |
Primary Erythermalgia
|
0.800 |
Biomarker
|
disease |
CTD_human |
Other mutations in SCN9A associated with more negative activation thresholds are known to cause primary erythermalgia (PE).
|
17145499 |
2006 |
Primary Erythermalgia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Other mutations in SCN9A associated with more negative activation thresholds are known to cause primary erythermalgia (PE).
|
17145499 |
2006 |
Primary Erythermalgia
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Inherited erythermalgia: limb pain from an S4 charge-neutral Na channelopathy.
|
16988069 |
2006 |
Primary Erythermalgia
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
A single sodium channel mutation produces hyper- or hypoexcitability in different types of neurons.
|
16702558 |
2006 |
Primary Erythermalgia
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Sporadic onset of erythermalgia: a gain-of-function mutation in Nav1.7.
|
16392115 |
2006 |
Primary Erythermalgia
|
0.800 |
GermlineCausalMutation
|
disease |
ORPHANET |
Gain-of-function mutation in Nav1.7 in familial erythromelalgia induces bursting of sensory neurons.
|
15958509 |
2005 |
Primary Erythermalgia
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Autosomal dominant erythermalgia associated with a novel mutation in the voltage-gated sodium channel alpha subunit Nav1.7.
|
16216943 |
2005 |